147 related articles for article (PubMed ID: 11087731)
21. Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts.
Sumitani S; Goya K; Testa JR; Kouhara H; Kasayama S
Endocrinology; 2002 Mar; 143(3):820-8. PubMed ID: 11861503
[TBL] [Abstract][Full Text] [Related]
22. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA.
Héron-Milhavet L; Mamaeva D; Rochat A; Lamb NJ; Fernandez A
J Cell Physiol; 2008 Jan; 214(1):158-65. PubMed ID: 17565718
[TBL] [Abstract][Full Text] [Related]
23. Developmental regulation of protein kinase B activation is isoform specific in skeletal muscle of neonatal pigs.
Suryawan A; Davis TA
Pediatr Res; 2005 Oct; 58(4):719-24. PubMed ID: 16189199
[TBL] [Abstract][Full Text] [Related]
24. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin.
Altomare DA; Lyons GE; Mitsuuchi Y; Cheng JQ; Testa JR
Oncogene; 1998 May; 16(18):2407-11. PubMed ID: 9620559
[TBL] [Abstract][Full Text] [Related]
25. Distinct activation mechanisms of protein kinase B by growth-factor stimulation and heat-shock treatment.
Matsuzaki H; Yamamoto T; Kikkawa U
Biochemistry; 2004 Apr; 43(14):4284-93. PubMed ID: 15065872
[TBL] [Abstract][Full Text] [Related]
26. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis.
Ueki K; Yamamoto-Honda R; Kaburagi Y; Yamauchi T; Tobe K; Burgering BM; Coffer PJ; Komuro I; Akanuma Y; Yazaki Y; Kadowaki T
J Biol Chem; 1998 Feb; 273(9):5315-22. PubMed ID: 9478990
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos.
Fiorenza MT; Russo G; Narducci MG; Bresin A; Mangia F; Bevilacqua A
J Cell Physiol; 2020 Apr; 235(4):3393-3401. PubMed ID: 31552693
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.
Gossett LA; Zhang W; Olson EN
J Cell Biol; 1988 Jun; 106(6):2127-37. PubMed ID: 3133379
[TBL] [Abstract][Full Text] [Related]
29. Functional and therapeutic significance of Akt deregulation in malignant melanoma.
Robertson GP
Cancer Metastasis Rev; 2005 Jun; 24(2):273-85. PubMed ID: 15986137
[TBL] [Abstract][Full Text] [Related]
30. Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors.
Sugatani T; Hruska KA
J Biol Chem; 2005 Feb; 280(5):3583-9. PubMed ID: 15545269
[TBL] [Abstract][Full Text] [Related]
31. Ribozymes targeting serine/threonine kinase Akt1 sensitize cells to anticancer drugs.
Yanagihara M; Katano M; Takahashi-Sasaki N; Kimata K; Taira K; Andoh T
Cancer Sci; 2005 Sep; 96(9):620-6. PubMed ID: 16128748
[TBL] [Abstract][Full Text] [Related]
32. A phosphatidylinositol 3-Kinase/p70 ribosomal S6 protein kinase pathway is required for the regulation by insulin of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase gene expression in human muscle cells.
Roques M; Vidal H
J Biol Chem; 1999 Nov; 274(48):34005-10. PubMed ID: 10567366
[TBL] [Abstract][Full Text] [Related]
33. Dual regulation of platelet protein kinase B.
Kroner C; Eybrechts K; Akkerman JW
J Biol Chem; 2000 Sep; 275(36):27790-8. PubMed ID: 10874027
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase B: emerging mechanisms of isoform-specific regulation of cellular signaling in cancer.
Wadhwa B; Makhdoomi U; Vishwakarma R; Malik F
Anticancer Drugs; 2017 Jul; 28(6):569-580. PubMed ID: 28379898
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin.
Tureckova J; Wilson EM; Cappalonga JL; Rotwein P
J Biol Chem; 2001 Oct; 276(42):39264-70. PubMed ID: 11500504
[TBL] [Abstract][Full Text] [Related]
36. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.
Coolican SA; Samuel DS; Ewton DZ; McWade FJ; Florini JR
J Biol Chem; 1997 Mar; 272(10):6653-62. PubMed ID: 9045696
[TBL] [Abstract][Full Text] [Related]
37. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.
Sasaoka T; Wada T; Fukui K; Murakami S; Ishihara H; Suzuki R; Tobe K; Kadowaki T; Kobayashi M
J Biol Chem; 2004 Apr; 279(15):14835-43. PubMed ID: 14744864
[TBL] [Abstract][Full Text] [Related]
38. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40.
Patel NA; Kaneko S; Apostolatos HS; Bae SS; Watson JE; Davidowitz K; Chappell DS; Birnbaum MJ; Cheng JQ; Cooper DR
J Biol Chem; 2005 Apr; 280(14):14302-9. PubMed ID: 15684423
[TBL] [Abstract][Full Text] [Related]
39. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells.
Pirola L; Bonnafous S; Johnston AM; Chaussade C; Portis F; Van Obberghen E
J Biol Chem; 2003 May; 278(18):15641-51. PubMed ID: 12594228
[TBL] [Abstract][Full Text] [Related]
40. Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.
Jiang ZY; Zhou QL; Holik J; Patel S; Leszyk J; Coleman K; Chouinard M; Czech MP
J Biol Chem; 2005 Jun; 280(22):21622-8. PubMed ID: 15799971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
